Welcome to LookChem.com Sign In|Join Free

CAS

  • or

934370-86-2

Post Buying Request

934370-86-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

934370-86-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 934370-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,3,7 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 934370-86:
(8*9)+(7*3)+(6*4)+(5*3)+(4*7)+(3*0)+(2*8)+(1*6)=182
182 % 10 = 2
So 934370-86-2 is a valid CAS Registry Number.

934370-86-2Relevant articles and documents

Method of preparing important intermediate 1-(9H-4-carbazoleoxy)-5-phenyl-2-pentanol of carvedilol

-

Paragraph 0005; 0018; 0019; 0020; 0021; 0022; 0023-0029, (2017/05/23)

The invention discloses a method of preparing an important intermediate, 1-(9H-4-carbazoleoxy)-5-phenyl-2-pentanol (I), of carvedilol and mainly solves the problem of influence of a side product, dimer, generated during a process of preparing the compound

Synthesis of new oxazolidinonyl/oxazolidinyl carbazole derivatives for β- blocking activity

Anumula, Raghupathi Reddy,Kagga, Mukkanti,Ghanta, Mahesh Reddy,Padi, Pratap Reddy

experimental part, p. 187 - 194 (2009/04/06)

Preparation of some new carbazolyloxy propanolamine derivatives and their cyclization into corresponding oxazolidinonyl/oxazolidinyl carbazole derivatives were described.

Novel heterocyclic compounds as pSTAT3/IL-6 inhibitors

-

Page/Page column 15, (2010/11/27)

The present invention relates to novel heterocyclic compounds of the general formula (I), as IL-6 inhibitors, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and compositions, their metabolites and prodrugs thereof. The present invention more particularly provides novel heterocyclic compounds of the general formula (I). Also included is a method for treatment of cancer, cancer cachexia and inflammatory diseases including immunological diseases, particularly those mediated by cytokines such as IL-6, through pSTAT3 inhibition, in a mammal comprising administering an effective amount of a compound of formula (I) as described above.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 934370-86-2